Atlas Trials

BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19)

Clinical trial NCT04494646 · COMPLETED

Trial details

NCT number
NCT04494646
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2020-09-08
Primary completion
2021-01-08
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.